ChemicalQDeviceImage Classification, MRI PET for AD Drug Clinical Trials
12/9/22 ChemicalQDevice "3D Scalable QCNNs for Image Classification, and MRI/PET for AD Drug Clinical Trials" References
[1] sQCNN-3D: https://arxiv.org/abs/2210.09728[2] Medical Imaging: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339628/[3] Multithread Registration: https://www.sciencedirect.com/science/article/abs/pii/S0169260719321479[4] Reconstruction: https://www.nature.com/articles/s41598-022-07221-4[5] Alzheimer's Trials: https://www.nia.nih.gov/research/ongoing-AD-trials[6] Roche Trial: https://clinicaltrials.gov/ct2/show/NCT03443973[7] Eli Lilly Trial: https://www.clinicaltrials.gov/ct2/show/NCT04437511[8] Eisai/Biogen Trial: https://clinicaltrials.gov/ct2/show/NCT03887455[9] ChemicalQDevice:  https://www.chemicalqdevice.com/[10] Medical Imaging: https://ieeexplore.ieee.org/document/9363915[11] Imaging Procedures: https://aws.amazon.com/blogs/machine-learning/new-amazon-healthlake-capabilities-enable-next-generation-imaging-solutions-and-precision-health-analytics/ [12] https://finance.yahoo.com/news/global-ai-medical-imaging-market-084600155.html
Created by Kevin Kawchak Founder CEO ChemicalQDevice2022 San Diego, CaliforniaHealthcare Innovation